Browsing Tag
Special Reports
58 posts
Value Creation in Procurement: Where Do Pharma Companies Stand?
By
How do Procurement organizations of the large and mid-size pharmaceutical and biopharmaceutical companies measure up in value-creation activities? The benchmarking study by the Drug, Chemical & Associated Technology Association (DCAT),…
FDA, Industry Experts Highlight Key Regulatory Changes at DCAT Week ’16
By
What are the major regulatory changes impacting active pharmaceutical ingredient (API) manufacturing and what is the business impact for pharmaceutical companies and their suppliers? From changes relating to starting materials,…
To Insource or Outsource Drug Product Development and Manufacturing? That is the Question
By
What is the optimal approach for pharmaceutical development and manufacturing? An upcoming DCAT Week ’16 education program provides first-hand insight from leading pharmaceutical companies on how they are approaching partnerships…